OCWP
RMD icon

Owl Creek Wealth Partners’s ResMed RMD Stock Holding History

Owl Creek Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9K Sell
169
-116
-41% -$24K 0.01% 495
2026
Q1 		$64K Buy
+285
New +$71K 0.02% 276

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Owl Creek Wealth Partners's RMD Position: Q2 2026 in Review

Owl Creek Wealth Partners reduced its ResMed (RMD) stake by 41% in Q2 2026, selling an estimated $24K and leaving 169 shares worth $32.9K. The position accounts for 0.01% of the portfolio, ranked #495.

Owl Creek Wealth Partners first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $64K in Q1 2026. 836 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Owl Creek Wealth Partners held 169 shares of ResMed worth $32.9K as of Q2 2026.
  • Owl Creek Wealth Partners sold 116 ResMed shares in Q2 2026, an estimated $24K.
  • ResMed made up 0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #495 holding.
  • Owl Creek Wealth Partners first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's ResMed position peaked at $64K in Q1 2026.
  • 836 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.